• Encision posted fiscal 2026 Q4 net loss of 96 (in $ thousands), narrowing from 314 in prior quarter.
• Net sales dropped 12.2% to 1,241 (in $ thousands) versus prior quarter.
• Operating loss narrowed to 60 (in $ thousands) from 299 in prior quarter.
• CEO Robert Fries said sales fell partly due to fewer selling days in January and February, citing procedure shifts toward Intuitive surgical robots.
• Management said restructuring cut targeted operating expenses, March was profitable on an operating income basis, and next quarter is expected to be profitable.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encision Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202604131115ACCESSWRNAPR_____1156983) on April 13, 2026, and is solely responsible for the information contained therein.